Effect of gastrointestinal lipase inhibitor combined with biguanides on serum estrogens in polycystic ovary syndrome with infertility
10.3969/j.issn.1005-1678.2016.08.014
- VernacularTitle:胃肠道脂肪酶抑制剂联合双胍类降糖药对肥胖伴多囊不孕女性血清雌激素水平的影响
- Author:
Chuanfa TU
;
Feixia SHEN
- Publication Type:Journal Article
- Keywords:
gastrointestinal lipase inhibitor;
metformin;
polycystic ovary syndrome with infertility;
estrogens
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(8):61-64
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of gastrointestinal lipase inhibitor combined with biguanides on serum estrogens in the treatment of polycystic ovary syndrome with infertility in patients.Methods 72 cases with polycystic ovary syndrome with infertility from Huangyan Hospital Affiliated to Wenzhou Medical University were selected and randomly divided into 2 groups, 36 cases of each group.The control group received conventional therapy, and the treatment group received more with orlistat, serological indicators, clinical symptoms, signs, pregnancy rate and ovulation rate were compared after the treatment.Results Compared with control group, levels of blood glucose and blood lipid index decreased in treatment group after treatment (P<0.05), the levels of luteinizing hormone (LH), follicles estrogen (FSH), estradiol (E2) and testosterone (T) decrease(P<0.05), levels of visfatin (VF) and leptin (LEP) decreased(P<0.05), adiponectin (APN) increased(P<0.05), and levels of BMI, WHR, hirsutism score and ovarian volume decreased (P<0.05).Compared with the control group(69.44%, 55.56%), the ovulation rate and pregnancy rate in the treatment (91.67%, 80.56%) were higher(P<0.05).Conclusion Gastrointestinal lipase inhibitor combined with biguanides could improve the pregnancy rate and ovulation rate in patients with polycystic ovary syndrome with infertility, reduce the levels of estrogens.
